Inhalation solution, like other beta2 agonists, can produce a clinically significant cardiovascular effect in some patients as measured by increases in pulse rate, systolic and or diastolic blood pressure, and or symptoms; if such effects occur, inhalation solution may need to be discontinued Beta agonists have been reported to produce ECG changes, such as flattening of T wave, prolongation of QTc interval, and ST segment depression; the clinical significance of these findings is unknown Inhalation solution, like other sympathomimetic amines, should be used with caution in patients with convulsive disorders or thyrotoxicosis, and in patients who are unusually responsive to sympathomimetic amines; doses of related beta2 agonist albuterol, when administered intravenously, have been reported to aggravate preexisting diabetes mellitus and ketoacidosis <a href=https://buycialis.buzz>where can i buy cialis on line</a>